Sponsored By

FDA Approves AF Suppression DeviceFDA Approves AF Suppression Device

FDA has approved what St. Jude Medical (St. Paul, MN) calls the first U.S. heart failure device to suppress atrial fibrillation (AF). The device, called the Atlas II + HF cardiac resynchronization therapy defibrillator, has a special algorithm that helps control the heart's atrial rhythm. It does this by pacing slightly faster than the patient's natural heart rate, according to the company.